Measurement of Blood Holoceruloplasmin by EIA Using a Mouse Monoclonal Antibody Directed to Holoceruloplasmin. Implication for Mass Screening of Wilson Disease

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 1994 Jan 1

PMID 7837770

Citations 4

Authors

F Endo

K Taketa

K Nakamura

H Awata

A Tanoue

Y Eda

I Matsuda

Affiliations

Soon will be listed here.

Citing Articles

Quantification of ATP7B Protein in Dried Blood Spots by Peptide Immuno-SRM as a Potential Screen for Wilson's Disease.

Jung S, Whiteaker J, Zhao L, Yoo H, Paulovich A, Hahn S J Proteome Res. 2016; 16(2):862-871.

PMID: 27935710 PMC: 5574172. DOI: 10.1021/acs.jproteome.6b00828.

Diagnostic Value of Ceruloplasmin in the Diagnosis of Pediatric Wilson's Disease.

Kim J, Kim H, Cho J, Oh S, Lee B, Kim G Pediatr Gastroenterol Hepatol Nutr. 2015; 18(3):187-92.

PMID: 26473139 PMC: 4600703. DOI: 10.5223/pghn.2015.18.3.187.

Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy.

Siotto M, Pasqualetti P, Marano M, Squitti R J Neural Transm (Vienna). 2014; 121(10):1281-6.

PMID: 24663495 DOI: 10.1007/s00702-014-1196-0.

Pilot study of screening for Wilson disease using dried blood spots obtained from children seen at outpatient clinics.

Ohura T, Abukawa D, Shiraishi H, Yamaguchi A, Arashima S, Hiyamuta S J Inherit Metab Dis. 1999; 22(1):74-80.

PMID: 10070620 DOI: 10.1023/a:1005455401076.

References

Endo F, Tanoue A, Kitano A, Arata J, Danks D, Lapiere C . Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes. J Clin Invest. 1990; 85(1):162-9. PMC: 296401. DOI: 10.1172/JCI114407. View

Matsuda I, Pearson T, Holtzman N . Determination of apoceruloplasmin by radioimmunoassay in nutritional copper deficiency, Menkes' kinky hair syndrome, Wilson's disease, and umbilical cord blood. Pediatr Res. 1974; 8(10):821-4. DOI: 10.1203/00006450-197410000-00001. View

Sato M, Gitlin J . Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem. 1991; 266(8):5128-34. View

Motohara K, Kuroki Y, Kan H, Endo F, Matsuda I . Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res. 1985; 19(4):354-7. DOI: 10.1203/00006450-198519040-00008. View

Holtzman N, Naughton M, Iber F, Gaumnitz B . Ceruloplasmin in Wilson's disease. J Clin Invest. 1967; 46(6):993-1002. PMC: 297104. DOI: 10.1172/JCI105606. View

Morell A, Scheinberg I . Preparation of an apoprotein from ceruloplasmin by reversible dissociation of copper. Science. 1958; 127(3298):588-90. DOI: 10.1126/science.127.3298.588-a. View

. Screening for inborn errors of metabolism. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1968; 401:1-57. View

SUNDERMAN Jr F, Nomoto S . Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem. 1970; 16(11):903-10. View

Tanzi R, Petrukhin K, Chernov I, Pellequer J, Wasco W, Ross B . The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993; 5(4):344-50. DOI: 10.1038/ng1293-344. View

10.

Bull P, Thomas G, Rommens J, FORBES J, Cox D . The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993; 5(4):327-37. DOI: 10.1038/ng1293-327. View

11.

Saito T . An assessment of efficiency in potential screening for Wilson's disease. J Epidemiol Community Health. 1981; 35(4):274-80. PMC: 1052177. DOI: 10.1136/jech.35.4.274. View